Rizzo, Manfredi

Lipid Levels in Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis

Wild, R. A., Rizzo, M., Clifton, S., & Carmina, E. (2011) · Fertility and Sterility

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 477

Relative Prevalence of Different Androgen Excess Disorders in 950 Women Referred because of Clinical Hyperandrogenism

Carmina, E., Rosato, F., Jannì, A., Rizzo, M., & Longo, R. A. (2006) · The Journal of Clinical Endocrinology & Metabolism

Ovarian function and disordersSexual Differentiation and Disorders

Cited by 420

Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

Cicero, A. F. G., Colletti, A., Bajraktari, G., Descamps, O., Djuric, D. M., Ezhov, M., Fras, Z., Katsiki, N., Langlois, M., Latkovskis, G., et al. (2017) · Archives of Medical Science

Lipoproteins and Cardiovascular HealthNatural Products and Biological Research

Cited by 281

The Role of Nutraceuticals in Statin Intolerant Patients

Banach, M., Patti, A. M., Giglio, R. V., Cicero, A. F. G., Atanasov, A. G., Bajraktari, G., Bruckert, E., Descamps, O., Djuric, D. M., Ezhov, M., et al. (2018) · Journal of the American College of Cardiology

Lipoproteins and Cardiovascular HealthNatural Products and Biological Research

Cited by 272

Association between metabolic syndrome and periodontitis: a systematic review and meta-analysis

Nibali, L., Tatarakis, N., Needleman, I., Tu, Y.-K., D'Aiuto, F., Rizzo, M., & Donos, N. (2013) · The Journal of Clinical Endocrinology & Metabolism

Oral microbiology and periodontitis researchDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 229

Efficacy of GLP-1 RA Approved for Weight Management in Patients With or Without Diabetes: A Narrative Review

Jensterle, M., Rizzo, M., Haluzík, M., & Janež, A. (2022) · Advances in Therapy

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 215

Evaluation of serum s-IgE/total IgE ratio in predicting clinical response to allergen-specific immunotherapy

Di Lorenzo, G., Mansueto, P., Pacor, M. L., Rizzo, M., Castello, F., Martinelli, N., Ditta, V., Lo Bianco, C., Leto-Barone, M. S., D'Alcamo, A., et al. (2009) · Journal of Allergy and Clinical Immunology

Allergic Rhinitis and SensitizationFood Allergy and Anaphylaxis Research

Cited by 210

Effects of Coenzyme Q10 on Statin-Induced Myopathy

Banach, M., Serban, C., Sahebkar, A., Ursoniu, S., Rysz, J., Muntner, P., Toth, P. P., Jones, S. R., Rizzo, M., Glasser, S. P., et al. (2015) · Mayo Clinic Proceedings

Coenzyme Q10 studies and effectsLipoproteins and Cardiovascular Health

Cited by 198

Statin therapy and plasma coenzyme Q10 concentrations—A systematic review and meta-analysis of placebo-controlled trials

Banach, M., Serban, C., Ursoniu, S., Rysz, J., Muntner, P., Toth, P. P., Jones, S. R., Rizzo, M., Glasser, S. P., Watts, G. F., et al. (2015) · Pharmacological Research

Coenzyme Q10 studies and effectsLipoproteins and Cardiovascular Health

Cited by 195

Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel: This paper is also published in parallel in Archives of Medical Science [Banach M, Rizzo M, Toth PP, et al. Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel. Arch Med Sci 2015; 11(1): 1–23]

Banach, M., Rizzo, M., Toth, P. P., Farnier, M., Davidson, M. H., Al-Rasadi, K., Aronow, W. S., Athyros, V., Djuric, D. M., Ezhov, M. V., et al. (2015) · Expert Opinion on Drug Safety

Lipoproteins and Cardiovascular HealthPharmacovigilance and Adverse Drug Reactions

Cited by 162

GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms

Rizzo, M., Nikolic, D., Patti, A. M., Mannina, C., Montalto, G., McAdams, B. S., Rizvi, A. A., & Cosentino, F. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 152

Once-daily liraglutide versus lixisenatide as add-on to metformin in type 2 diabetes: a 26-week randomized controlled clinical trial

Nauck, M., Rizzo, M., Johnson, A., Bosch-Traberg, H., Madsen, J., & Cariou, B. (2016) · Diabetes Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 143

Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study

Rizzo, M., Rizvi, A. A., Patti, A. M., Nikolic, D., Giglio, R. V., Castellino, G., Li Volti, G., Caprio, M., Montalto, G., Provenzano, V., et al. (2016) · Cardiovascular Diabetology

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 135

The role of fibrate treatment in dyslipidemia: an overview

Katsiki, N., Nikolic, D., Montalto, G., Banach, M., Mikhailidis, D. P., & Rizzo, M. (2013) · Current Pharmaceutical Design

Lipoproteins and Cardiovascular HealthPeroxisome Proliferator-Activated Receptors

Cited by 131

Atherogenic Lipoprotein Phenotype and Low-Density Lipoproteins Size and Subclasses in Women with Polycystic Ovary Syndrome

Berneis, K., Rizzo, M., Lazzaroni, V., Fruzzetti, F., & Carmina, E. (2007) · The Journal of Clinical Endocrinology & Metabolism

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 121

Liraglutide Reduces Oxidative Stress and Restores Heme Oxygenase-1 and Ghrelin Levels in Patients with Type 2 Diabetes: A Prospective Pilot Study

Rizzo, M., Abate, N., Chandalia, M., Rizvi, A. A., Giglio, R. V., Nikolic, D., Marino Gammazza, A., Barbagallo, I., Isenovic, E. R., Banach, M., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism

Diabetes Treatment and ManagementHeme Oxygenase-1 and Carbon Monoxide

Cited by 113

Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?

Cicero, A. F. G., Fogacci, F., Stoian, A. P., Vrablik, M., Al Rasadi, K., Banach, M., Toth, P. P., & Rizzo, M. (2021) · Current Atherosclerosis Reports

Lipoproteins and Cardiovascular HealthNatural Products and Biological Research

Cited by 110

Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy--a meta-analysis of 11 randomized controlled trials involving 21,295 participants

Barylski, M., Nikfar, S., Mikhailidis, D. P., Toth, P. P., Salari, P., Ray, K. K., Pencina, M. J., Rizzo, M., Rysz, J., Abdollahi, M., et al. (2013) · Pharmacological Research

Lipoproteins and Cardiovascular HealthChronic Kidney Disease and Diabetes

Cited by 98

Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome

Berneis, K., Rizzo, M., Hersberger, M., Rini, G. B., Di Fede, G., Pepe, I., Spinas, G. A., & Carmina, E. (2009) · International Journal of Clinical Practice

Ovarian function and disordersLipoproteins and Cardiovascular Health

Cited by 94

Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect

Nikolic, D., Giglio, R. V., Rizvi, A. A., Patti, A. M., Montalto, G., Maranta, F., Cianflone, D., Stoian, A. P., & Rizzo, M. (2021) · Diabetes Therapy

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 81

Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease

Rizzo, M., Pernice, V., Frasheri, A., & Berneis, K. (2008) · Atherosclerosis

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 75

Gut microbiota and aging-A focus on centenarians

Cӑtoi, A. F., Corina, A., Katsiki, N., Vodnar, D. C., Andreicuț, A. D., Stoian, A. P., Rizzo, M., & Pérez-Martínez, P. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Gut microbiota and healthProbiotics and Fermented Foods

Cited by 70

Emerging therapies for raising high-density lipoprotein cholesterol (HDL-C) and augmenting HDL particle functionality

Barylski, M., Toth, P. P., Nikolic, D., Banach, M., Rizzo, M., & Montalto, G. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 67

Metabolic effect of berberine–silymarin association: A meta‐analysis of randomized, double‐blind, placebo‐controlled clinical trials

Fogacci, F., Grassi, D., Rizzo, M., & Cicero, A. F. G. (2019) · Phytotherapy Research

Berberine and alkaloids researchNatural Antidiabetic Agents Studies

Cited by 61